Ak4 Enzyme Powers Macrophage Antibacterial Defense
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- National Taiwan University researchers found that adenylate kinase 4 (Ak4) strengthens macrophage antibacterial defense by promoting mitochondrial DNA (mtDNA) synthesis and boosting mitochondrial reactive oxygen species (mtROS) production during bacterial infection.
- The study, published in the Journal of Experimental Medicine (2026), shows that loss of Ak4 impairs mtDNA synthesis, reduces mtROS output, and weakens macrophages' ability to clear bacteria.
- Mice lacking Ak4 exhibited higher bacterial burdens and increased susceptibility to infection, demonstrating the enzyme's role in vivo.
- Mechanistically, Ak4 regulates nucleotide metabolism required for mtDNA replication, and disrupting its enzymatic activity abolishes the antibacterial effect, linking cellular metabolism directly to immune defense.
- Corresponding author Prof. Shi-Chuen Miaw of NTU's Graduate Institute of Immunology described Ak4 as "a key metabolic regulator that enables macrophages to mount effective antibacterial responses."
- The authors frame the findings as revealing a previously unrecognized pathway connecting mitochondrial function and innate immunity, with potential implications for modulating immune responses in infectious and inflammatory diseases.
Why it matters: The work identifies a specific, druggable molecular node — Ak4 — that links mitochondrial nucleotide metabolism to innate immune killing, and the in vivo mouse data confirm that losing Ak4 measurably raises infection susceptibility. That gives researchers a concrete target for designing host-directed therapies that boost macrophage defense against bacterial pathogens, distinct from conventional antibiotics.
Ask SkimNews
